173 related articles for article (PubMed ID: 1985172)
1. How American oncologists treat breast cancer: an assessment of the influence of clinical trials.
Belanger D; Moore M; Tannock I
J Clin Oncol; 1991 Jan; 9(1):7-16. PubMed ID: 1985172
[TBL] [Abstract][Full Text] [Related]
2. Use of a physician-directed questionnaire to define a consensus about management of breast cancer: implications for assessing costs and benefits of treatment.
Tannock IF; Belanger D
J Natl Cancer Inst Monogr; 1992; (11):137-42. PubMed ID: 1627419
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
Rajagopal S; Goodman PJ; Tannock IF
J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
[TBL] [Abstract][Full Text] [Related]
4. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
[TBL] [Abstract][Full Text] [Related]
5. Management of Localized Breast Angiosarcoma by North American Radiation and Medical Oncologists.
Hatfield J; McClelland S; Luo J; Degnin C; Chen Y; Maggiore RJ; Mitin T
Clin Breast Cancer; 2018 Dec; 18(6):498-503. PubMed ID: 30482726
[TBL] [Abstract][Full Text] [Related]
6. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
9. Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey.
Coroneos CJ; Roth-Albin K; Rai AS; Rai AS; Voineskos SH; Brouwers MC; Avram R; Heller B
Breast; 2017 Apr; 32():60-65. PubMed ID: 28038321
[TBL] [Abstract][Full Text] [Related]
10. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
11. Treatment choices for patients with invasive lobular breast cancer: a doctor survey.
Jacobs C; Ibrahim MF; Clemons M; Hutton B; Simos D; Caudrelier JM; Graham ID; Smith S; Addison C; Arnaout A
J Eval Clin Pract; 2015 Aug; 21(4):740-8. PubMed ID: 26059404
[TBL] [Abstract][Full Text] [Related]
12. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists.
Barni S; Collovà E; Frassoldati A; Amoroso D
Future Oncol; 2015; 11(8):1181-9. PubMed ID: 25832875
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Goldhirsch A; Gelber R
NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
16. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
17. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1996 Nov; 348(9036):1189-96. PubMed ID: 8898035
[TBL] [Abstract][Full Text] [Related]
18. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists' preferences.
Stiggelbout AM; de Haes JC; van de Velde CJ
Ann Oncol; 2000 May; 11(5):631-3. PubMed ID: 10907961
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
